Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Evan

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Biology|October 1, 1988
The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAsJ De Greve, J Battey, J Fedorko, et al.
Oncogene|March 4, 1998
Specific TrkA survival signals interfere with different apoptotic pathwaysE Ulrich, A Duwel, A Kauffmann-Zeh, et al.
ACS Chemical Biology|July 22, 2016
A Fluorescent Transport Assay Enables Studying AmpG Permeases Involved in Peptidoglycan Recycling and Antibiotic ResistanceG Evan Perley-Robertson, Anuj K Yadav, Judith L Winogrodzki, et al.
Biochimica Et Biophysica Acta|June 10, 1992
Down-regulation of cellular proto-oncogenes during inhibition of rat parotid acinar cell proliferationS W Lee, K R Purushotham, T Littlewood, et al.
British Journal of Cancer|November 1, 1989
c-myc oncogene product expression and prognosis in operable breast cancerA P Locker, C S Dowle, I O Ellis, et al.
Chembiochem : a European Journal of Chemical Biology|September 7, 2013
The development of selective inhibitors of NagZ: increased susceptibility of Gram-negative bacteria to β-lactamsKeith A Stubbs, John-Paul Bacik, G Evan Perley-Robertson, et al.
Neuron|April 1, 1990
Differential expression of immediate early genes in the hippocampus and spinal cordW Wisden, M L Errington, S Williams, et al.
The EMBO Journal|August 1, 1985
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycleP H Rabbitts, J V Watson, A Lamond, et al.
Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.
Oncogene|October 18, 2016
OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumorsL A Jung, A Gebhardt, W Koelmel, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Biology|October 1, 1988
The human L-myc gene encodes multiple nuclear phosphoproteins from alternatively processed mRNAsJ De Greve, J Battey, J Fedorko, et al.
Oncogene|March 4, 1998
Specific TrkA survival signals interfere with different apoptotic pathwaysE Ulrich, A Duwel, A Kauffmann-Zeh, et al.
ACS Chemical Biology|July 22, 2016
A Fluorescent Transport Assay Enables Studying AmpG Permeases Involved in Peptidoglycan Recycling and Antibiotic ResistanceG Evan Perley-Robertson, Anuj K Yadav, Judith L Winogrodzki, et al.
Biochimica Et Biophysica Acta|June 10, 1992
Down-regulation of cellular proto-oncogenes during inhibition of rat parotid acinar cell proliferationS W Lee, K R Purushotham, T Littlewood, et al.
British Journal of Cancer|November 1, 1989
c-myc oncogene product expression and prognosis in operable breast cancerA P Locker, C S Dowle, I O Ellis, et al.
Chembiochem : a European Journal of Chemical Biology|September 7, 2013
The development of selective inhibitors of NagZ: increased susceptibility of Gram-negative bacteria to β-lactamsKeith A Stubbs, John-Paul Bacik, G Evan Perley-Robertson, et al.
Neuron|April 1, 1990
Differential expression of immediate early genes in the hippocampus and spinal cordW Wisden, M L Errington, S Williams, et al.
The EMBO Journal|August 1, 1985
Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycleP H Rabbitts, J V Watson, A Lamond, et al.
Journal of Medicinal Chemistry|February 7, 2003
3-(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-alkyl-N-arylbenzamides: potent, non-peptidic agonists of both the micro and delta opioid receptorsMichael J Bishop, Dulce M Garrido, G Evan Boswell, et al.
Oncogene|October 18, 2016
OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumorsL A Jung, A Gebhardt, W Koelmel, et al.
Pageof 7